GPT and fatty liver disease: NMN decreased weight gain, serum AST and ALT levels and intrahepatic TG content and ameliorated hepatic steatosis and mitochondrial structural injuries in HFD-fed Hint2−/− mice (Supplementary Fig. 5f–i).